Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Assess Ketamine-induced Changes in ERP Biomarkers in Healthy Volunteers

NCT04928703 is registered in ClinicalTrials.gov with ERP Biomarker Qualification Consortium as lead sponsor.

NCT NCT04928703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04928703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Assess Ketamine-induced Changes in ERP Biomarkers in Healthy Volunteers
Lead sponsor
ERP Biomarker Qualification Consortium
Phase
Phase 1
Overall status
Completed
Start date
May 26, 2022
Completion date
December 12, 2022
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy